InvestorsHub Logo
Followers 88
Posts 5985
Boards Moderated 0
Alias Born 03/19/2007

Re: None

Saturday, 04/11/2015 1:51:30 AM

Saturday, April 11, 2015 1:51:30 AM

Post# of 97081
Wondering what Kind of acquistion they will announce but it Shows to me, they are full power ahead and what is best, DECN has the backing of some strong shareholders to do all this. If this is not a sign of trust - what then?

And soon, those big shareholders will be rewarded with Performance as the rope around the neck of J&J is getting tight.



The Registrant is unable to file its quarterly report on Form 10-K within the prescribed time period due to a material event now in
process. The Registrant’s subsidiary Pharma Tech Solutions, Inc. is completing an acquisition of certain healthcare assets from a
privately owned concern and this event also includes changes of registration with federal regulatory bodies as well as primary private
registrars. This event transaction closing is expected to be completed by April 14, 2014.
Decision Diagnostics Corp.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
By: /s/ Keith M. Berman
Keith M. Berman, Principal Executive Officer

(3)
Date: March